Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Melanie Everitt to Graft Rejection

This is a "connection" page, showing publications Melanie Everitt has written about Graft Rejection.

 
Connection Strength
  
 
 
4.197
  
  1. Everitt MD, Pahl E, Koehl DA, Cantor RS, Kirklin JK, Reed AC, Thrush P, Zinn M, McCormick AD, Yester J, Schauer JS, Lee DW. Clinical outcomes after a biopsy diagnosis of antibody-mediated rejection in pediatric heart transplant recipients. J Heart Lung Transplant. 2025 Jan; 44(1):82-91.
    View in: PubMed
    Score: 0.675
  2. Nakano SJ, Everitt MD. Beyond the biopsy: Is it time to change the gold standard for rejection diagnosis in clinical decision-making and scientific discovery? J Heart Lung Transplant. 2022 10; 41(10):1414-1416.
    View in: PubMed
    Score: 0.591
  3. Kleinmahon JA, Gralla J, Kirk R, Auerbach SR, Henderson HT, Wallis GA, Ramakrishnan K, Singh RK, Caldwell RL, Savage AJ, Everitt MD. Cardiac allograft vasculopathy and graft failure in pediatric heart transplant recipients after rejection with severe hemodynamic compromise. J Heart Lung Transplant. 2019 03; 38(3):277-284.
    View in: PubMed
    Score: 0.455
  4. Ware AL, Malmberg E, Delgado JC, Hammond ME, Miller DV, Stehlik J, Kfoury A, Revelo MP, Eckhauser A, Everitt MD. The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children. J Heart Lung Transplant. 2016 Feb; 35(2):179-85.
    View in: PubMed
    Score: 0.364
  5. Everitt MD, Hammond ME, Snow GL, Stehlik J, Revelo MP, Miller DV, Kaza AK, Budge D, Alharethi R, Molina KM, Kfoury AG. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant. J Heart Lung Transplant. 2012 Jul; 31(7):686-93.
    View in: PubMed
    Score: 0.287
  6. Everitt MD, Pahl E, Schechtman KB, Zheng J, Ringewald JM, L'ecuyer T, Naftel DC, Kirklin JK, Blume ED, Bullock EA, Canter CE. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study. J Heart Lung Transplant. 2011 Mar; 30(3):282-8.
    View in: PubMed
    Score: 0.258
  7. Almond CS, Daly KP, Albers EL, Alejos JC, Ameduri R, Auerbach SR, Barkoff L, Barnes AP, Bock MJ, Butto A, Carlo WF, Castleberry CD, Chrisant MR, Deshpande SR, Dreyer WJ, Everitt MD, Feingold B, Gonzales S, Hollander SA, Kindel SJ, Klein GL, Lal AK, Lamour JM, Lee J, Lu M, Lytrivi ID, Miyamoto SD, Pahl E, Peng DM, Ryan TD, Singh TP, Su JA, Sutcliffe DL, Ybarra AM, Zangwill S, Rossano JW, Sleeper LA. Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial. JAMA. 2025 Oct 21; 334(15):1339-1348.
    View in: PubMed
    Score: 0.183
  8. Downs EA, Schäfer M, Everitt MD, Aubrey M, Mitchell M, Jaggers J, Campbell D, Stone ML. Inclusive ABO-Incompatible Listing for Pediatric Heart Transplantation Results in Comparable Post-Transplant Rejection-Free Survival in a Single-Center Series. Pediatr Cardiol. 2025 Oct; 46(7):1925-1931.
    View in: PubMed
    Score: 0.168
  9. Bae EK, Chandran MM, Everitt MD, Benz E, Bock M. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients. Clin Transplant. 2024 Aug; 38(8):e15417.
    View in: PubMed
    Score: 0.168
  10. Wolfe KR, Kelly SL, Steinberg E, Pliego J, Everitt MD. Predictors of neuropsychological functioning and medication adherence in pediatric heart transplant recipients referred for neuropsychological evaluation. Pediatr Transplant. 2020 02; 24(1):e13615.
    View in: PubMed
    Score: 0.121
  11. Castleberry C, Ziniel S, Almond C, Auerbach S, Hollander SA, Lal AK, Fenton M, Pahl E, Rossano JW, Everitt MD, Daly KP. Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment. Pediatr Transplant. 2017 Aug; 21(5).
    View in: PubMed
    Score: 0.103
  12. Almond CS, Hoen H, Rossano JW, Castleberry C, Auerbach SR, Yang L, Lal AK, Everitt MD, Fenton M, Hollander SA, Pahl E, Pruitt E, Rosenthal DN, McElhinney DB, Daly KP, Desai M. Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. J Heart Lung Transplant. 2018 04; 37(4):441-450.
    View in: PubMed
    Score: 0.101
  13. Chanana N, Van Dorn CS, Everitt MD, Weng HY, Miller DV, Menon SC. Alteration of Cardiac Deformation in Acute Rejection in Pediatric Heart Transplant Recipients. Pediatr Cardiol. 2017 Apr; 38(4):691-699.
    View in: PubMed
    Score: 0.100
  14. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol. 2012 Nov-Dec; 21(6):445-54.
    View in: PubMed
    Score: 0.071
  15. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2012 Jan; 31(1):46-51.
    View in: PubMed
    Score: 0.070
  16. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J. Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant. 2011 Dec; 11(12):2755-61.
    View in: PubMed
    Score: 0.069
  17. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG. Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant. 2011 Feb; 30(2):144-50.
    View in: PubMed
    Score: 0.064
  18. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li DY, Li Y, Kfoury AG. Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc. 2010 Sep; 42(7):2687-92.
    View in: PubMed
    Score: 0.064
  19. Kfoury AG, Hammond ME, Snow GL, Drakos SG, Stehlik J, Fisher PW, Reid BB, Everitt MD, Bader FM, Renlund DG. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant. 2009 Aug; 28(8):781-4.
    View in: PubMed
    Score: 0.059
  20. Kfoury AG, Renlund DG, Snow GL, Stehlik J, Folsom JW, Fisher PW, Reid BB, Clayson SE, Gilbert EM, Everitt MD, Bader FM, Singhal AK, Hammond ME. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant. 2009 Jan; 28(1):51-7.
    View in: PubMed
    Score: 0.057
  21. Amdani S, Henderson H, Everitt MD, Beasley G, Shih R, Exil V, Alejos J, Wallis G, Azeka E, Nandi D, Profita E, Spinner J, Magnetta D, Martinez H, Fenton M, Conway J, Urschel S. Clinical approach to antibody-mediated rejection from the pediatric heart transplant society. Pediatr Transplant. 2022 12; 26(8):e14398.
    View in: PubMed
    Score: 0.037
  22. Bansal N, Everitt MD, Nandi D, Spinner J, Conway J, Magnetta DA, Profita EL, Townsend M, Alejos JC, Deshpande SR. Clinical approach to acute cellular rejection from the pediatric heart transplant society. Pediatr Transplant. 2022 12; 26(8):e14393.
    View in: PubMed
    Score: 0.037
  23. Chen TT, Greene MM, Everitt MD, Simpson KE. Basiliximab as maintenance immunosuppression in heart transplant recipients: A single pediatric center experience. Pediatr Transplant. 2023 03; 27(2):e14438.
    View in: PubMed
    Score: 0.037
  24. Lin Y, Davis TJ, Zorrilla-Vaca A, Wojcik BM, Miyamoto SD, Everitt MD, Campbell DN, Jaggers JJ, Rajab TK. Neonatal heart transplant outcomes: A single institutional experience. J Thorac Cardiovasc Surg. 2021 Nov; 162(5):1361-1368.
    View in: PubMed
    Score: 0.033
  25. Thrush PT, Pahl E, Naftel DC, Pruitt E, Everitt MD, Missler H, Zangwill S, Burch M, Hoffman TM, Butts R, Mahle WT. A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes. J Heart Lung Transplant. 2016 12; 35(12):1497-1504.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)